At our recent CNSA Breast Cancer Community of Practice meeting, members came together with Marisa Stevens and Jenny Gilchrist to unpack the latest insights from the Breast Cancer Trials Conference and explore their relevance for nursing practice.
Immunotherapy is transforming care for early triple negative breast cancer, but it brings unique challenges in adverse event (AE) management. This webinar will guide cancer nurses through recognising and managing immune-related AEs associated with KEYTRUDA®, including patient education, when to escalate care, and how to handle complex issues like endocrinopathies.
Reasearch shows that long-term cancer survivors are about 40% more likely to die from cardiovascular disease than the general population as a result of cancer treatment toxicity and shared risk factors.
You are invited to provide feedback to the Commission. Your input will help shape the new standards and ensure they are relevant, evidence-based, responsive to emerging challenges and innovations and outcomes-focused.